PharmacoGx statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.


Citations per year

Citations chart

Popular tool citations

chevron_left Pharmacogenetics chevron_right
Popular tools chart

Tool usage distribution map

Tool usage distribution map

Associated diseases

Associated diseases

PharmacoGx specifications


Unique identifier OMICS_11097
Name PharmacoGx
Software type Package/Module
Interface Command line interface
Restrictions to use None
Operating system Unix/Linux, Mac OS, Windows
License Artistic License version 2.0
Computer skills Advanced
Version 1.1.4
Stability Stable
Maintained Yes



Add your version



  • person_outline Benjamin Haibe-Kains <>

Publication for PharmacoGx

PharmacoGx in publications

PMCID: 5869697
PMID: 29588458
DOI: 10.1038/s41598-018-23195-8

[…] sample signatures, normal sample signatures were generated by comparing each normal sample versus all the other normal samples., a preprocessed version of the cmap database was downloaded using the pharmacogx package (version 1.6.1) which was corrected for systematic differences caused by the different microarray platforms using the combat function in the sva package (version 3.10.0)., […]

PMCID: 5655668
PMID: 29066719
DOI: 10.1038/s41467-017-01153-8

[…] and more significantly associated with drug sensitivity than overall gene expression, opening new avenues for future biomarker discovery for in vitro and in vivo drug screening., we used our pharmacogx platform to create curated, annotated, and standardized pharmacogenomic datasets, which comprises ccle, gcsi, gdsc, and gray (supplementary table ). ccle, gcsi, and gray pharmacological […]

PMCID: 5580432
PMID: 28928933
DOI: 10.5256/f1000research.10354.r16370

[…] study that can be applied to another study. research reproducibility. the code we provided with our original paper was incompatible with updated releases of the gdsc and ccle datasets. we developed pharmacogx, which is a flexible, open-source software package based on the statistical language r, and used it to derive the results reported here. , in 2013 we reported inconsistency in the drug […]

PMCID: 5239501
PMID: 27322211
DOI: 10.18632/oncotarget.10010

[…] have made this data available for downloading through the qapc portal. alternatively, auc can be calculated for the specified range of drug concentrations using functions from the recently published pharmacogx package in r [] (at this time, the pharmacogx analysis is limited to the data from ccle and gdsc databases) or by using the code from our downloadable bioinformatics pipeline., […]

PMCID: 4926729
PMID: 27408686
DOI: 10.5256/f1000research.9367.r14316

[…] and lines 10-11 of, all analyses were performed using the most updated version of the gdsc and ccle pharmacogenomic data based on our pharmacogx package (version 1.1.4)., all analyses were performed using the most updated version of the gdsc and ccle pharmacogenomic data based on our pharmacogx package (version 1.1.4). pharmacogx […]

To access a full list of publications, you will need to upgrade to our premium service.

PharmacoGx institution(s)
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada; Institut De Recherches Cliniques De Montréal, Montreal, QC, Canada; Interuniversity Institute of Bioinformatics in Brussels (IB)2, Brussels, Belgium; Machine Learning Group (MLG), Department d’Informatique, Université libre de Bruxelles (ULB), Brussels, Belgium; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA, Department of Bioinformatics, Boston University, Boston, MA, USA; Beth Israel Deaconess Medical Center, Boston, MA, USA; Ontario Institute of Cancer Research, Toronto, ON, Canada; Hospital for Sick Children, Toronto, ON, Canada; Department of Computer Science, University of Toronto, Toronto, ON, Canada
PharmacoGx funding source(s)
This work was supported by the Canadian Cancer Research Society and the Ontario Institute for Cancer Research.

PharmacoGx reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review PharmacoGx